Abstract
Traditionally, many innovations in digestive surgery were first evaluated using cholecystectomies in humans as an in vivo model. The large number of patients in good condition, the non-reconstructive nature of such an intervention, and the availability of a standardized operative technique for comparison are the main characteristics predisposing gallbladder surgery for assessment of new technologies. The first case of single-port laparoscopic cholecystectomy (SPLC) in the world was reported in 1997 by Navarra and the first case in Korea was reported in 2009. Since then, the use of SPLC has grown rapidly and several randomized controlled trials found that it is safe and feasible compared with conventional laparoscopic cholecystectomy. However, the true advantage of SPLC over conventional surgery remains controversial.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
